Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 4

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 4
---
 As of 2022, Dr. Touitou still has interest in working with WEED to complete the purchase of her patents
and begin clinical trials upon proper funding. WEED looks to achieve that funding thru offerings of our securities.

4

Cannabis Genomic Study

After more than 50 years
of illicit, underground breeding programs, the genetic integrity of Cannabis has been significantly degraded. WEED Inc. owns and or controls
over 250 cultivars from 1970 “Landrace Strains” to include Panama Red, Acapulco Gold, Red Bud Colombian, Thailand, G13, Santa
Marta Gold and Afghan pure strains currently for research purposes until proper licensing can be acquired. Our subsidiary, Sangre AT,
LLC (“Sangre”) plans to use a gene-based breeding program to root out inferior cultivars and replace them with fully-validated
and patentable cultivars which produce consistent plant products for the medicinal and Adult use markets. We believe our unique gene-based
breeding program will improve cultivars and introduce integrity, stability, and quality to the market in the following ways:

    ●
    Accelerated and optimized growth rates; modern genomic resources will enhance traditional breeding methods

    ●
    Generation of new cultivars, accelerating and perfecting the art of selective breeding

    ●
    Provide the ability to assay for specific genes within the crop, which is critical to strain tracking and market quality assurance

    ●
    Improve disease and drought resistance

We believe our gene-based
breeding program will facilitate and accelerate:

    ●
    Improved therapeutic properties

    ●
    New therapies for migraines/chronic pain, epilepsy, cancer, PTSD, chronic head injury, and others

    ●
    Enhanced opportunities for new drug discovery through collaborations with national and international medical research/treatment centers, bio-pharma companies including nutraceuticals and botanical companies

    ●
    Development and protection of intellectual property on a global scale. WEED currently owns several trademarks for WEED, WEED Rules!, Panama Red and Acapulco Gold in several countries in certain limited International categories as placeholders for future growth.

The Research Plan

In order to achieve the
desired results outlined above, Sangre has developed a research plan entitled the “Cannabis Genomic Study.” The goal
of the study is to complete a global genomic classification of the Cannabis plant genus. Once the classification is complete, the research
team plans to develop new cannabis and industrial hemp strains